Microwave ablation of the T1a small renal mass: expanding beyond 3 cm by Qiu, Jessica, Ballantyne, Christopher, Yeaman, Clint, Lange, Moritz, Morgan, John, Mershon, J. Patrick, Richie, Iman, DeNovio, Anthony, Clements, Matthew B., Krupski, Tracey L., Schenkman, Noah, Lobo, Jennifer M.

Get full text

A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial by Edwards, Jr, John E, Schwartz, Michael M, Schmidt, Clint S, Sobel, Jack D, Nyirjesy, Paul, Schodel, Florian, Marchus, Erica, Lizakowski, Mary, DeMontigny, Elizabeth A, Hoeg, Jesse, Holmberg, Tuomas, Cooke, M Timothy, Hoover, Keila, Edwards, Lance, Jacobs, Mark, Sussman, Steven, Augenbraun, Michael, Drusano, Michael, Yeaman, Michael R, Ibrahim, Ashraf S, Filler, Scott G, Hennessey, Jr, John P

Get full text

Mechanisms of NDV-3 vaccine efficacy in MRSA skin versus invasive infection by Yeaman, Michael R, Filler, Scott G, Chaili, Siyang, Barr, Kevin, Wang, Huiyuan, Kupferwasser, Deborah, Hennessey, Jr, John P, Fu, Yue, Schmidt, Clint S, Edwards, Jr, John E, Xiong, Yan Q, Ibrahim, Ashraf S

Get full text

Nonredundant Roles of Interleukin-17A (IL-17A) and IL-22 in Murine Host Defense against Cutaneous and Hematogenous Infection Due to Methicillin-Resistant Staphylococcus aureus by Chan, Liana C, Chaili, Siyang, Filler, Scott G, Barr, Kevin, Wang, Huiyuan, Kupferwasser, Deborah, Edwards, Jr, John E, Xiong, Yan Q, Ibrahim, Ashraf S, Miller, Lloyd S, Schmidt, Clint S, Hennessey, Jr, John P, Yeaman, Michael R

Get full text

NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus , is safe and immunogenic in healthy adults by Schmidt, Clint S, White, C. Jo, Ibrahim, Ashraf S, Filler, Scott G, Fu, Yue, Yeaman, Michael R, Edwards Jr., John E, Hennessey Jr., John P

Get full text

NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response by Ibrahim, Ashraf S, Luo, Guanpingsheng, Gebremariam, Teclegiorgis, Lee, Hongkyu, Schmidt, Clint S, Hennessey, John P, French, Samuel W, Yeaman, Michael R, Filler, Scott G, Edwards, John E

Get full text

Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis by Uppuluri, Priya, Singh, Shakti, Alqarihi, Abdullah, Schmidt, Clint S, Hennessey, Jr, John P, Yeaman, Michael R, Filler, Scott G, Edwards, John E, Ibrahim, Ashraf S

Get full text

Applying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureus by Yeaman, Michael R, Filler, Scott G, Schmidt, Clint S, Ibrahim, Ashraf S, Edwards, Jr, John E, Hennessey, Jr, John P

Get full text

Mechanisms of NDV-3 vaccine efficacy in MRSA skin versus invasive infection by Yeaman, Michael R., Filler, Scott G., Chaili, Siyang, Barr, Kevin, Wang, Huiyuan, Kupferwasser, Deborah, Hennessey, John P., Fu, Yue, Schmidt, Clint S., Edwards, John E., Xiong, Yan Q., Ibrahim, Ashraf S.

Get full text

NDV-3, a recombinant alum-adjuvanted vaccine forCandidaandStaphylococcus aureus, is safe and immunogenic in healthy adults by Schmidt, Clint S, White, C Jo, Ibrahim, Ashraf S, Filler, Scott G, Fu, Yue, Yeaman, Michael R, Edwards Jr, John E, Hennessey Jr, John P

Get full text